ORACLE INVESTMENT MANAGEMENT INC - Q4 2017 holdings

$503 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 24 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 60.0% .

 Value Shares↓ Weighting
OPK BuyOPKO HEALTH INC$18,751,000
-24.8%
3,826,760
+5.2%
3.73%
-8.9%
BIOL BuyBIOLASE INC$13,161,000
+19.2%
30,866,262
+68.5%
2.62%
+44.3%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$6,899,000
+20.0%
1,032,721
+47.1%
1.37%
+45.4%
ARNA BuyARENA PHARMACEUTICALS INC$4,778,000
+191.0%
140,666
+118.5%
0.95%
+252.8%
SLNO NewSOLENO THERAPEUTICS INC$4,299,0002,388,060
+100.0%
0.85%
CFRX BuyCONTRAFECT CORP$2,929,000
+20.9%
2,900,417
+32.9%
0.58%
+46.6%
ELGX NewENDOLOGIX INC$1,941,000362,727
+100.0%
0.39%
QDEL NewQUIDEL CORPcall$729,000104,800
+100.0%
0.14%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
OPKO HEALTH INC42Q3 202310.6%
PACIFIC BIOSCIENCES CALIF IN42Q3 202322.6%
BIOGEN INC42Q3 20230.6%
QUIDEL CORP36Q1 202252.5%
AMARIN CORP PLC31Q3 202123.1%
VERMILLION INC28Q1 20203.8%
AGENUS INC25Q3 20239.8%
TESARO INC23Q4 201827.8%
ACCELERATE DIAGNOSTICS INC23Q2 202323.0%
MAZOR ROBOTICS LTD20Q1 201818.0%

View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.

Compare quarters

Export ORACLE INVESTMENT MANAGEMENT INC's holdings